![]() |
|
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Received for publication May 24, 2006.
Revised January 29, 2007.
Accepted for publication January 30, 2007.
Epoxyeicosatrienoic acids (EETs) have been reported to contract intralobar pulmonary arteries (PA) of the rabbit in a cyclooxygenase (COX)-dependent manner. In the present study, we observed that COX-1 and COX-2 isoforms were expressed in freshly isolated PA of healthy rabbits. We examined the hypothesis that both COX isoforms participate in 5,6-EET-induced contraction of rabbit intralobar PA. Selective inhibition of COX-1 with SC-560 (300 nM) prevented 5,6-EET (1 x 10-8 to 1 x 10-5 M) -induced contractions of isolated intralobar rabbit PA rings in a manner similar to that observed with the non-selective cyclooxygenase inhibitor, indomethacin (10 µM). Selective inhibition of COX-2 with either DUP-697 (100 nM) or NS-398 (3 µM) shifted the EC50 of 5,6-EET-induced PA contraction to the right, but with considerably lower efficacy than SC-560. In rabbit PA, 5,6-EET-induced contraction was primarily dependent on COX-1 activity. Differential metabolism of 5,6-EET by COX-1 and COX-2 does not explain the primary dependence of PA contraction on COX-1 activity since 5,6-EET was metabolized similarly by both COX isoforms. COX-1 and 2 were expressed primarily in PA endothelium where COX-1 expression was dense and uniform, while COX-2 expression was sparse and non-uniform. 5,6-EET-induced PA contraction was endothelium-dependent. These results suggest that 5,6-EET-induced contraction is primarily dependent on COX-1 activity.
Key words:
DUP-697, NS-398, SC-560, cytochrome P-450, indomethacin, lung
This article has been cited by other articles:
![]() |
N. Dragin, Z. Shi, R. Madan, C. L. Karp, M. A. Sartor, C. Chen, F. J. Gonzalez, and D. W. Nebert Phenotype of the Cyp1a1/1a2/1b1(-/-) Triple-Knockout Mouse Mol. Pharmacol., June 1, 2008; 73(6): 1844 - 1856. [Abstract] [Full Text] [PDF] |
||||